BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 12670925)

  • 1. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
    Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
    Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
    Shida D; Kitayama J; Yamaguchi H; Hama K; Aoki J; Arai H; Yamashita H; Mori K; Sako A; Konishi T; Watanabe T; Sakai T; Suzuki R; Ohta H; Takuwa Y; Nagawa H
    Exp Cell Res; 2004 Dec; 301(2):168-78. PubMed ID: 15530853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells.
    Goetzl EJ; Dolezalova H; Kong Y; Zeng L
    Cancer Res; 1999 Sep; 59(18):4732-7. PubMed ID: 10493533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid-induced effects in human colon carcinoma DLD1 cells are partially dependent on transactivation of epidermal growth factor receptor.
    Mori K; Kitayama J; Shida D; Yamashita H; Watanabe T; Nagawa H
    J Surg Res; 2006 May; 132(1):56-61. PubMed ID: 16289596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta.
    Chen SU; Lee H; Chang DY; Chou CH; Chang CY; Chao KH; Lin CW; Yang YS
    Endocrinology; 2008 Nov; 149(11):5888-96. PubMed ID: 18617617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid signaling through LPA receptor subtype 1 induces colony scattering of gastrointestinal cancer cells.
    Shin KJ; Kim YL; Lee S; Kim DK; Ahn C; Chung J; Seong JY; Hwang JI
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):45-52. PubMed ID: 18592268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
    Kim J; Keys JR; Eckhart AD
    Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid signaling via LPA
    Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
    Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
    Wang FQ; Ariztia EV; Boyd LR; Horton FR; Smicun Y; Hetherington JA; Smith PJ; Fishman DA
    Gynecol Oncol; 2010 Apr; 117(1):88-95. PubMed ID: 20056268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid regulates the proliferation and migration of olfactory ensheathing cells in vitro.
    Yan H; Lu D; Rivkees SA
    Glia; 2003 Oct; 44(1):26-36. PubMed ID: 12951654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
    Hope JM; Wang FQ; Whyte JS; Ariztia EV; Abdalla W; Long K; Fishman DA
    Gynecol Oncol; 2009 Jan; 112(1):215-23. PubMed ID: 19019417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade.
    Miyabe Y; Miyabe C; Iwai Y; Yokoyama W; Sekine C; Sugimoto K; Harigai M; Miyasaka M; Miyasaka N; Nanki T
    Arthritis Res Ther; 2014 Oct; 16(5):461. PubMed ID: 25273676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
    Hu YL; Albanese C; Pestell RG; Jaffe RB
    J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells.
    Saatian B; Zhao Y; He D; Georas SN; Watkins T; Spannhake EW; Natarajan V
    Biochem J; 2006 Feb; 393(Pt 3):657-68. PubMed ID: 16197369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome.
    Chen SU; Chou CH; Lee H; Ho CH; Lin CW; Yang YS
    J Clin Endocrinol Metab; 2008 Mar; 93(3):935-43. PubMed ID: 18171700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3.
    Lin CI; Chen CN; Lin PW; Chang KJ; Hsieh FJ; Lee H
    Biochem Biophys Res Commun; 2007 Nov; 363(4):1001-8. PubMed ID: 17923111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
    Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
    J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
    Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
    J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
    Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
    Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.